GTR 52967973
Tenders are invited for Ocrelizumab, Teriflunomide, Delamanide, Linezolid, Bedaquiline, Lopinavir Ritonavir, Milk Formula
ICB — International Competitive Bid
Closed
Western Asia
Tender Information
GTR Reference
52967973
Tendering Authority
Subscribe to view
Tender No
Med10/2022/A
Financer Name
Self-Funded
Work Title
Tenders are invited for Ocrelizumab, Teriflunomide, Delamanide, Linezolid, Bedaquiline, Lopinavir Ritonavir, Milk Formula
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Asia
Political Region
Arab World,Middle East,Middle East and North Africa MENA
Last Date of Bid Submission
26-07-2022
Closed
Work Detail
Tenders Are Invited For Ocrelizumab 300 Mg/10Ml Vial, Teriflunomide 14 Mg Tablet, Delamanide 50Mg Tablet, Linezolid 600 Mg Tab, Bedaquiline 100Mg Tablet, Lopinavir + Ritonavir 80/20Mg/Ml, Milk Formula For Infants As A Sole Source Of Nutrition Or As Supplementary Feed For Children, Etc. Payment Of A Nonrefundable Fee With Lump Sum As Follows: A- (1.000.000)One Million Iraqi Dinar Of The Tender That Less Than (1.000.000) Dollars .B- (2.000.000)Two Million Iraqi Dinar For The Tender That More Than (1.000.000) Dinar. A Bid Security At Ratio 1%. Tender Link :
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
e2937d44-10f0-47ed-9f32-62a13e2d7268.htm
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.